招商證券(06099.HK)將每10股配3股配售股份
格隆匯7月12日丨招商證券(06099.HK)公佈,本次A股配股以本次A股發行股權登記日2020年7月9日(T日)上交所收市後公司A股總股本5,719,008,149股為基數,按每10股配3股的比例向全體A股股東配售,共計可配股份數量1,715,702,444股,均為無限售條件流通股。
本次A股配股網上申購期間公司A股股票停牌,2020年7月17日(T+6日)中國證券登記結算有限責任公司上海分公司網上清算,公司A股股票繼續停牌,2020年7月20日(T+7日)刊登A股配股發行結果公告,公司A股股票復牌交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.